H.B. Fuller Company (FUL)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · FUL
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $54 FUL trades at 12× p/e, below its 17× p/e peer median. Our $64 fair value sits above the price. It's a high-confidence read. Analysts target $58–$71. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $67.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $11.71 | — | — | Hist. CAGR | high |
| graham number | 12M | $62.01 | — | — | TTM | high |
| Peer P/FCF | 12M | $53.89 | 21.1 | 2.56 | TTM | high |
| Peer P/E | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$58.00 – $71.00 (median $67.00) · 6 analysts · as of 2026-06-26
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $78.45 |
| 17.4 |
| 4.52 |
| TTM |
| high |
| Peer P/S | 12M | $92.30 | 1.4 | 63.70 | TTM | high |
| PEG | 12M | $109.99 | 24.3 | 4.52 | TTM | high |
| residual income | 12M | $41.02 | — | — | TTM | high |
| Own P/E history | 12M | $65.35 | 14.5 | 4.52 | TTM | high |
| triangulated | 12M | $81.99 | 17.4 | 4.72 | Triangulated | high |
| Peer P/FCF | 3Y | $32.90 | 21.1 | 1.56 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $109.16 | 17.4 | 6.29 | Analyst | medium |
| Peer P/S | 3Y | $121.91 | 1.4 | 84.14 | Analyst | medium |
| PEG | 3Y | $153.05 | 24.3 | 6.29 | Analyst | medium |
| Own P/E history | 3Y | $90.92 | 14.5 | 6.29 | Analyst | medium |
| Peer P/FCF | 5Y | $23.68 | 21.1 | 1.12 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $130.90 | 17.4 | 7.54 | Analyst | high |
| Peer P/S | 5Y | $146.20 | 1.4 | 100.90 | Analyst | high |
| PEG | 5Y | $183.54 | 24.3 | 7.54 | Analyst | high |
| Own P/E history | 5Y | $109.04 | 14.5 | 7.54 | Analyst | high |